SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001723128-19-000105
Filing Date
2019-08-05
Accepted
2019-08-05 06:13:55
Documents
3
Period of Report
2019-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K currentreportonform8-k2019.htm 8-K 71523
2 AMENDED AND RESTATED BYLAWS amnealamendedrestatedbylaw.htm EX-3.1 143617
3 PRESS RELEASE DATED AUGUST 5, 2019 pressrelease20190805.htm EX-99.1 28362
  Complete submission text file 0001723128-19-000105.txt   244847
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 19997457
SIC: 2834 Pharmaceutical Preparations